nodes	percent_of_prediction	percent_of_DWPC	metapath
MACITENTAN—ALB—chronic obstructive pulmonary disease	0.416	1	CbGaD
MACITENTAN—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0796	0.188	CbGbCtD
MACITENTAN—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0796	0.188	CbGbCtD
MACITENTAN—ALB—Prednisone—chronic obstructive pulmonary disease	0.0516	0.121	CbGbCtD
MACITENTAN—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0508	0.12	CbGbCtD
MACITENTAN—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0343	0.0808	CbGbCtD
MACITENTAN—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0334	0.0788	CbGbCtD
MACITENTAN—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0327	0.0771	CbGbCtD
MACITENTAN—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0292	0.0687	CbGbCtD
MACITENTAN—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0171	0.0403	CbGbCtD
MACITENTAN—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0162	0.0381	CbGbCtD
MACITENTAN—Influenza—Roflumilast—chronic obstructive pulmonary disease	0.00265	0.0387	CcSEcCtD
MACITENTAN—Infestation NOS—Roflumilast—chronic obstructive pulmonary disease	0.00236	0.0345	CcSEcCtD
MACITENTAN—Infestation—Roflumilast—chronic obstructive pulmonary disease	0.00236	0.0345	CcSEcCtD
MACITENTAN—Urinary tract infection—Roflumilast—chronic obstructive pulmonary disease	0.0023	0.0335	CcSEcCtD
MACITENTAN—Infection—Roflumilast—chronic obstructive pulmonary disease	0.0015	0.0218	CcSEcCtD
MACITENTAN—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00148	0.0216	CcSEcCtD
MACITENTAN—Urinary tract infection—Tiotropium—chronic obstructive pulmonary disease	0.00144	0.0211	CcSEcCtD
MACITENTAN—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00139	0.0203	CcSEcCtD
MACITENTAN—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.0203	CcSEcCtD
MACITENTAN—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00136	0.0199	CcSEcCtD
MACITENTAN—Influenza—Formoterol—chronic obstructive pulmonary disease	0.00134	0.0196	CcSEcCtD
MACITENTAN—Influenza—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.0196	CcSEcCtD
MACITENTAN—Pharyngitis—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.0193	CcSEcCtD
MACITENTAN—Influenza—Montelukast—chronic obstructive pulmonary disease	0.00132	0.0192	CcSEcCtD
MACITENTAN—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.0192	CcSEcCtD
MACITENTAN—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.00129	0.0189	CcSEcCtD
MACITENTAN—Bronchitis—Formoterol—chronic obstructive pulmonary disease	0.00129	0.0189	CcSEcCtD
MACITENTAN—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.0185	CcSEcCtD
MACITENTAN—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.00127	0.0185	CcSEcCtD
MACITENTAN—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.0178	CcSEcCtD
MACITENTAN—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00121	0.0177	CcSEcCtD
MACITENTAN—Infestation—Montelukast—chronic obstructive pulmonary disease	0.00117	0.0171	CcSEcCtD
MACITENTAN—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.00117	0.0171	CcSEcCtD
MACITENTAN—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.017	CcSEcCtD
MACITENTAN—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.00117	0.017	CcSEcCtD
MACITENTAN—Fluid retention—Prednisolone—chronic obstructive pulmonary disease	0.0011	0.0161	CcSEcCtD
MACITENTAN—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.0161	CcSEcCtD
MACITENTAN—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00107	0.0156	CcSEcCtD
MACITENTAN—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.0156	CcSEcCtD
MACITENTAN—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00105	0.0153	CcSEcCtD
MACITENTAN—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.0147	CcSEcCtD
MACITENTAN—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000998	0.0146	CcSEcCtD
MACITENTAN—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000985	0.0144	CcSEcCtD
MACITENTAN—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000948	0.0138	CcSEcCtD
MACITENTAN—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000944	0.0138	CcSEcCtD
MACITENTAN—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000941	0.0137	CcSEcCtD
MACITENTAN—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000939	0.0137	CcSEcCtD
MACITENTAN—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000929	0.0136	CcSEcCtD
MACITENTAN—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000922	0.0135	CcSEcCtD
MACITENTAN—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000801	0.0117	CcSEcCtD
MACITENTAN—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000765	0.0112	CcSEcCtD
MACITENTAN—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000765	0.0112	CcSEcCtD
MACITENTAN—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00076	0.0111	CcSEcCtD
MACITENTAN—Infection—Formoterol—chronic obstructive pulmonary disease	0.00076	0.0111	CcSEcCtD
MACITENTAN—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00075	0.0109	CcSEcCtD
MACITENTAN—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00075	0.0109	CcSEcCtD
MACITENTAN—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000749	0.0109	CcSEcCtD
MACITENTAN—Infection—Montelukast—chronic obstructive pulmonary disease	0.000744	0.0109	CcSEcCtD
MACITENTAN—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000735	0.0107	CcSEcCtD
MACITENTAN—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000722	0.0105	CcSEcCtD
MACITENTAN—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000717	0.0105	CcSEcCtD
MACITENTAN—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000715	0.0104	CcSEcCtD
MACITENTAN—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000715	0.0104	CcSEcCtD
MACITENTAN—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000708	0.0103	CcSEcCtD
MACITENTAN—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000675	0.00985	CcSEcCtD
MACITENTAN—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000629	0.00919	CcSEcCtD
MACITENTAN—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000594	0.00866	CcSEcCtD
MACITENTAN—Headache—Formoterol—chronic obstructive pulmonary disease	0.000479	0.00699	CcSEcCtD
MACITENTAN—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000479	0.00699	CcSEcCtD
MACITENTAN—Headache—Montelukast—chronic obstructive pulmonary disease	0.000469	0.00685	CcSEcCtD
MACITENTAN—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000452	0.0066	CcSEcCtD
MACITENTAN—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000414	0.00604	CcSEcCtD
MACITENTAN—ALB—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000388	0.00425	CbGpPWpGaD
MACITENTAN—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000384	0.00561	CcSEcCtD
MACITENTAN—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000375	0.00412	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000375	0.00411	CbGpPWpGaD
MACITENTAN—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000361	0.00396	CbGpPWpGaD
MACITENTAN—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.00036	0.00394	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000355	0.0039	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000353	0.00387	CbGpPWpGaD
MACITENTAN—EDNRA—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000343	0.00376	CbGpPWpGaD
MACITENTAN—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000341	0.00497	CcSEcCtD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000339	0.00371	CbGpPWpGaD
MACITENTAN—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000337	0.00369	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.000328	0.00359	CbGpPWpGaD
MACITENTAN—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000326	0.00358	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000324	0.00355	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000317	0.00348	CbGpPWpGaD
MACITENTAN—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000313	0.00343	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000309	0.00338	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000307	0.00336	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000302	0.00332	CbGpPWpGaD
MACITENTAN—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000301	0.00439	CcSEcCtD
MACITENTAN—EDNRA—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.0003	0.00329	CbGpPWpGaD
MACITENTAN—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0003	0.00329	CbGpPWpGaD
MACITENTAN—Infection—Prednisone—chronic obstructive pulmonary disease	0.000299	0.00436	CcSEcCtD
MACITENTAN—ALB—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.000298	0.00327	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000297	0.00325	CbGpPWpGaD
MACITENTAN—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000297	0.00325	CbGpPWpGaD
MACITENTAN—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000295	0.00431	CcSEcCtD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.000284	0.00312	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000278	0.00305	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000275	0.00301	CbGpPWpGaD
MACITENTAN—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000273	0.00299	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000271	0.00297	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000268	0.00294	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000265	0.00291	CbGpPWpGaD
MACITENTAN—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000262	0.00288	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.00026	0.00286	CbGpPWpGaD
MACITENTAN—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000259	0.00379	CcSEcCtD
MACITENTAN—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000259	0.00284	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000259	0.00284	CbGpPWpGaD
MACITENTAN—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000256	0.00281	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000256	0.00281	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000254	0.00279	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000253	0.00277	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000246	0.0027	CbGpPWpGaD
MACITENTAN—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000246	0.00269	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000244	0.00267	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000242	0.00265	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000232	0.00254	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.00023	0.00253	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000227	0.00249	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000221	0.00243	CbGpPWpGaD
MACITENTAN—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000218	0.00239	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000216	0.00237	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000214	0.00235	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000212	0.00232	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000211	0.00232	CbGpPWpGaD
MACITENTAN—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00021	0.0023	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000199	0.00218	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000196	0.00215	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000194	0.00212	CbGpPWpGaD
MACITENTAN—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000193	0.00211	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00019	0.00209	CbGpPWpGaD
MACITENTAN—Headache—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00275	CcSEcCtD
MACITENTAN—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000188	0.00207	CbGpPWpGaD
MACITENTAN—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000186	0.00204	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000183	0.00201	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000174	0.00191	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000173	0.0019	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.000172	0.00189	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000172	0.00188	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00017	0.00186	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000169	0.00186	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000163	0.00178	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000162	0.00178	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000159	0.00175	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000158	0.00174	CbGpPWpGaD
MACITENTAN—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000156	0.00171	CbGpPWpGaD
MACITENTAN—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000154	0.00169	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000153	0.00168	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000153	0.00168	CbGpPWpGaD
MACITENTAN—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000153	0.00167	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000151	0.00166	CbGpPWpGaD
MACITENTAN—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00014	0.00154	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000139	0.00152	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000137	0.0015	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000137	0.0015	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000136	0.00149	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000134	0.00147	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000133	0.00146	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000132	0.00145	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000132	0.00145	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	0.000132	0.00145	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000131	0.00143	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000131	0.00143	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.00013	0.00143	CbGpPWpGaD
MACITENTAN—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.00139	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000124	0.00136	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000123	0.00135	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000121	0.00133	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.00012	0.00131	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000119	0.0013	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000116	0.00127	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000115	0.00126	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.000113	0.00124	CbGpPWpGaD
MACITENTAN—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.00124	CbGpPWpGaD
MACITENTAN—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.00123	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000112	0.00122	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00121	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000109	0.0012	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000109	0.00119	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	0.000108	0.00119	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.000108	0.00118	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000105	0.00115	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000105	0.00115	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	9.94e-05	0.00109	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	9.78e-05	0.00107	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	9.59e-05	0.00105	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.56e-05	0.00105	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.44e-05	0.00104	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.36e-05	0.00103	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.35e-05	0.00103	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	9.31e-05	0.00102	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.31e-05	0.00102	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.18e-05	0.00101	CbGpPWpGaD
MACITENTAN—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.18e-05	0.00101	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.89e-05	0.000975	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	8.88e-05	0.000974	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.55e-05	0.000938	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.55e-05	0.000938	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	8.54e-05	0.000937	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.44e-05	0.000925	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.2e-05	0.000899	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.11e-05	0.000889	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.08e-05	0.000886	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8e-05	0.000877	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.98e-05	0.000875	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	7.81e-05	0.000856	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	7.8e-05	0.000856	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.77e-05	0.000852	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	7.74e-05	0.000849	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	7.44e-05	0.000816	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.38e-05	0.00081	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.33e-05	0.000804	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	7.27e-05	0.000797	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	7.17e-05	0.000786	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	6.88e-05	0.000755	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.84e-05	0.00075	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	6.83e-05	0.000749	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	6.82e-05	0.000748	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.71e-05	0.000736	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.7e-05	0.000735	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.66e-05	0.000731	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.62e-05	0.000726	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	6.52e-05	0.000716	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.41e-05	0.000703	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.36e-05	0.000697	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	6.3e-05	0.000691	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	6.2e-05	0.00068	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.96e-05	0.000654	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	5.91e-05	0.000648	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.87e-05	0.000644	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.6e-05	0.000614	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.52e-05	0.000605	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	5.3e-05	0.000582	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.28e-05	0.00058	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.24e-05	0.000575	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.18e-05	0.000568	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.14e-05	0.000564	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.07e-05	0.000556	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	5.03e-05	0.000552	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	5e-05	0.000549	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.9e-05	0.000537	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.88e-05	0.000535	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.81e-05	0.000528	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.81e-05	0.000527	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.8e-05	0.000526	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	4.78e-05	0.000524	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.77e-05	0.000524	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.77e-05	0.000523	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GC—chronic obstructive pulmonary disease	4.68e-05	0.000514	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.68e-05	0.000513	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.65e-05	0.00051	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.59e-05	0.000503	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.46e-05	0.00049	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.35e-05	0.000477	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.32e-05	0.000474	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.29e-05	0.00047	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.27e-05	0.000468	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	4.2e-05	0.000461	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.96e-05	0.000434	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.92e-05	0.00043	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.91e-05	0.000429	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.77e-05	0.000413	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.73e-05	0.00041	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.58e-05	0.000393	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.51e-05	0.000385	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.47e-05	0.00038	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	3.46e-05	0.00038	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	3.42e-05	0.000375	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	3.35e-05	0.000368	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.35e-05	0.000367	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.22e-05	0.000353	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.2e-05	0.00035	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	3.18e-05	0.000349	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.11e-05	0.000342	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	3.08e-05	0.000338	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.95e-05	0.000324	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.89e-05	0.000317	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.83e-05	0.000311	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.7e-05	0.000296	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.6e-05	0.000285	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.6e-05	0.000285	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.56e-05	0.000281	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.56e-05	0.000281	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	2.53e-05	0.000277	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.53e-05	0.000277	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.48e-05	0.000272	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.43e-05	0.000267	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.35e-05	0.000258	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	2.31e-05	0.000253	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.3e-05	0.000252	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.3e-05	0.000252	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	2.27e-05	0.000249	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.22e-05	0.000244	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.13e-05	0.000233	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.12e-05	0.000232	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.11e-05	0.000232	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.07e-05	0.000227	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	2.07e-05	0.000227	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.91e-05	0.000209	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.78e-05	0.000196	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.77e-05	0.000194	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.75e-05	0.000192	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.74e-05	0.000191	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.64e-05	0.00018	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.63e-05	0.000179	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.59e-05	0.000175	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.59e-05	0.000175	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.57e-05	0.000172	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.54e-05	0.000169	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.46e-05	0.00016	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.39e-05	0.000152	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.38e-05	0.000151	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.37e-05	0.00015	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	1.35e-05	0.000148	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.25e-05	0.000137	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.15e-05	0.000126	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	1e-05	0.00011	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.57e-06	0.000105	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.44e-06	0.000104	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	9.43e-06	0.000103	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	9.02e-06	9.89e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.8e-06	9.65e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.34e-06	9.15e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.67e-06	6.22e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.42e-06	5.95e-05	CbGpPWpGaD
